On November 19, GHTC hosted a virtual roundtable with four organizations advancing COVID-19 innovations and 12 staff members from congressional offices. The dialogue focused on the need for COVID-19 innovations designed for use in low-resource settings and the role the US Agency for International Development (USAID) could play in supporting this effort. Read on for a recap of the event.

With support from the US Agency for International Development’s (USAID) global health Grand Challenges for Development program led by the Center for Innovation and Impact, global innovators have been designing and scaling up affordable solutions to the world’s most significant global health challenges. With the toll of COVID-19 now intensifying in low- and middle-income countries, many of these innovations are turning their attention to this new challenge.

The COVID-19 pandemic is a global health crisis affecting populations around the world. GHTC is tracking and responding to the pandemic through US and multilateral efforts.

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Rohit Ramchandani, who we met at the American Society of Tropical Medicine and Hygiene Annual Conferenc. Dr. Ramchandani does research to innovate global treatment options for childhood diarrhea at the Johns Hopkins School of Public Health in Baltimore, Maryland and the University of Waterloo. 

Faces of Innovation—a new GHTC project that features scientists on the front lines of research and development on new global health tools and technologies—profiles Dr. Mohammad Nuhu Amin, who we met at the American Society of Tropical Medicine and Hygiene Annual Conference. Dr. Amin researches sanitation and diarrheal diseases with support from the United States Agency for International Development.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC held a Game changers in global health game night on Capitol Hill to educate Congressional staffers about the impact of US leadership in global health research and development (R&D). Our guests ate, drank, played games, and learned how US investments in global health R&D not only saves lives around the world, but also generates benefits here at home in the United States. Here are some of our favorite photos.

On February 15, President Trump signed into law a bipartisan spending bill—averting another partial government shutdown and ensuring full-year funding for the government for the remainder of fiscal year 2019. The months-long saga ended with some great news for global health and research and development.

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

On February 5, President Trump delivered his second State of the Union address. Among the long list of policy proposals and pledges in the speech was one of great interest to the global health research community—an announcement of a new whole-of-government plan to eliminate HIV transmission in the United States by 2030.

As the partial government shutdown stretches into a fifth week – the longest in United States history – news of its impact on agencies essential to global health broadly, and research and development in particular, is taking clearer shape.

President Trump signed into law a spending bill that pairs full-year fiscal year (FY) 2019 funding for Labor, Health and Human Services (LHHS) and Defense with a stopgap measure to keep other agencies funded through December—staving off a partial government shutdown on the eve of the end of the fiscal year. Here’s a breakdown of how global health and medical research funding fared.

For many mothers and babies around the world, the first 48 hours after birth are the most dangerous of their lives. For eight years, Saving Lives at Birth—spearheaded by USAID—has challenged problem solvers worldwide to create innovative solutions to make birth safer and save lives. Here are ten incredible innovations from this initiative:

What global health R&D advocates need to know about the 2018 omnibus spending bill.

USAID’s latest report to Congress demonstrates how strategic R&D investments are driving positive global health outcomes and saving American taxpayers money

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...